Provided by Tiger Trade Technology Pte. Ltd.

Apellis Pharmaceuticals Inc.

19.79
-0.2783-1.39%
Volume:575.29K
Turnover:11.34M
Market Cap:2.53B
PE:114.80
High:20.12
Open:20.00
Low:19.34
Close:20.07
52wk High:30.48
52wk Low:16.10
Shares:127.83M
Float Shares:78.12M
Volume Ratio:0.38
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.1724
EPS(LYR):0.1724
ROE:7.48%
ROA:3.53%
PB:6.84
PE(LYR):114.80

Loading ...

Feb 27, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 28, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 09, 2020

Major Issues Report

Current report, items 1.01 and 8.01
Jan 07, 2020

Major Issues Report

Current report, item 2.02
Jan 07, 2020

Major Issues Report

Current report, item 8.01
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Oct 07, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Sep 16, 2019

Major Issues Report

Current report, items 1.01, 2.03, 3.02, 8.01, and 9.01
Sep 12, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Sep 11, 2019

Major Issues Report

Current report, items 7.01 and 9.01
Jul 31, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 21, 2019

Major Issues Report

Current report, item 5.07
Jun 10, 2019

Major Issues Report

Current report, item 1.01
May 24, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
May 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Apr 12, 2019

Major Issues Report

Current report, items 4.01 and 9.01